These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 1585676)
1. [Therapeutic possibilities in systemic scleroderma]. Sönnichsen N; Brenke A Z Arztl Fortbild (Jena); 1992 Mar; 86(5):227-30. PubMed ID: 1585676 [No Abstract] [Full Text] [Related]
2. [Clinical study of autoimmune diseases: recent trends--with special reference to progress in immunological tests and therapeutic methods. Systemic autoimmune diseases. 2) Systemic scleroderma and polymyositis]. Kinoshita M; Yokohari R Nihon Rinsho; 1988 Apr; 46(4):873-8. PubMed ID: 3261361 [No Abstract] [Full Text] [Related]
3. [The clinical picture and therapy of progressive systemic scleroderma]. Sönnichsen N; Brenke A; Witt C Dtsch Med Wochenschr; 1992 Mar; 117(11):427-31. PubMed ID: 1544345 [No Abstract] [Full Text] [Related]
4. [The local therapy of systemic scleroderma]. Guseva NG Ter Arkh; 1990; 62(5):110-3. PubMed ID: 2396204 [No Abstract] [Full Text] [Related]
5. [Determination of antinuclear autoantibodies in progressive systemic sclerosis and its clinical significance]. Jiang M; Wang HZ; Yuan X Zhonghua Nei Ke Za Zhi; 1988 Feb; 27(2):112-4, 136. PubMed ID: 3053068 [No Abstract] [Full Text] [Related]
7. Autoantibodies against nuclear, nucleolar, and mitochondrial antigens in systemic sclerosis (scleroderma). Reimer G Rheum Dis Clin North Am; 1990 Feb; 16(1):169-83. PubMed ID: 2406806 [TBL] [Abstract][Full Text] [Related]
8. [Prognosis and treatment of scleroderma]. Crickx B; Belaich S Ann Med Interne (Paris); 1984; 135(8):624-9. PubMed ID: 6529058 [TBL] [Abstract][Full Text] [Related]
10. The pathogenic role of autoantibodies to nuclear autoantigens in systemic sclerosis (scleroderma). Senécal JL; Hénault J; Raymond Y J Rheumatol; 2005 Sep; 32(9):1643-9. PubMed ID: 16142854 [No Abstract] [Full Text] [Related]
11. [Determination of anti-Scl-70 antibody and its clinical significance in progressive systemic sclerosis]. Jiang M Zhonghua Yi Xue Za Zhi; 1986 Jun; 66(6):346-8, 384. PubMed ID: 3094898 [No Abstract] [Full Text] [Related]
12. [Effectiveness of long-term use of dimethyl sulfoxide in the complex treatment of patients with systemic scleroderma]. Murav'ev IuV; Aliab'eva AP; Sigidin IaA; Guseva NG; Balabanova RM Ter Arkh; 1985; 57(8):125-7. PubMed ID: 3906994 [No Abstract] [Full Text] [Related]
18. [Demonstration of antinuclear factors using indirect immunofluorescence in scleroderma patients]. Nebe H; Blume N Dermatol Monatsschr; 1971 Jan; 157(1):27-31. PubMed ID: 4938251 [No Abstract] [Full Text] [Related]
19. [Comparison of three methods for the detection of anti-SCL70 autoantibodies]. Yalaoui S; Gorgi Y; Ayed K Ann Biol Clin (Paris); 2001; 59(5):639-42. PubMed ID: 11602398 [No Abstract] [Full Text] [Related]
20. [Generalized scleroderma associated at with active chronic hepatitis. Successive apparition of different serum antibodies]. Husson JM; Petite JP; Homberg JC; Lunel J; Audebert A; Camilleri JP Nouv Presse Med; 1974 Dec; 3(45):2717-21. PubMed ID: 4549263 [No Abstract] [Full Text] [Related] [Next] [New Search]